Aug 2026· Cardiovascular Diagnosis and Therapy· Vol 16, pp. 69-69· 0 citations· 35 references
Medicine
TL;DR
The integrated analysis reveals the central role of the cardiac inflammatory immune microenvironment in HF and identifies 65 key genes causally associated with HF susceptibility, which provide a basis for developing new biomarkers and immune-targeted therapies.
Abstract
Background Heart failure (HF) is a major global cause of cardiovascular death and disability. Chronic inflammation and immune dysregulation are critical in its development. The cardiac immune microenvironment, especially macrophages, drives HF progression, yet its molecular mechanisms and prognostic impact are not fully clear. This study aimed to identify causal immune-related driver genes in the HF inflammatory microenvironment. Methods We combined single-cell RNA sequencing (scRNA-seq) and Mendelian randomization (MR) to study how the inflammatory immune microenvironment affects HF risk. Using two public scRNA-seq datasets, we identified differentially expressed genes (DEGs) in HF heart tissues and selected 489 candidate genes. Causal relationships between these genes and HF were tested using expression quantitative trait loci (eQTL) data and HF genome-wide association study (GWAS) summary statistics. Results MR analysis showed that 65 genes were causally linked to HF risk. These genes were enriched in pathways related to cardiomyopathy, leukocyte migration, natural killer (NK) cell cytotoxicity, neutrophil extracellular traps, and NF-κB signaling. HF hearts displayed increased levels of macrophages, T cells, B cells, lymphoid cells, and mast cells, while neutrophils were reduced. Conclusions Our integrated analysis reveals the central role of the cardiac inflammatory immune microenvironment in HF and identifies 65 key genes causally associated with HF susceptibility. These genes influence specific immune pathways and cell infiltration, shaping HF progression, and provide a basis for developing new biomarkers and immune-targeted therapies.
This sc-eQTL MR study reveals immune cell-specific causal regulatory networks in PCOS, where GLIPR1 in non-classical monocytes represents a high-confidence protective target, while XBP1 provides suggestive evidence for immune-mediated pathogenesis.
Jia-Huan Zhang, Yi-Kai Liu, Dan-Hong Lin et al.· Science in progress· 0 citations
This study prioritized several mitochondria-related genes associated with sepsis susceptibility based on human genetic evidence to provide candidate targets for further mechanistic and translational investigation.
Lu Wang, Zhen Gao, Cheng-Jin Wang et al.· Frontiers in Immunology· 0 citations
BACKGROUND
Coronary heart disease (CHD) remains a leading cause of morbidity and mortality worldwide, with immune and inflammatory mechanisms playing important roles in its pathogenesis. Dendritic cells (DCs) are key regulators of immune responses; however, the relationship between specific DC subsets and CHD risk rema...
Feng Lv, Li-Hong Zhou, Rong-Rong Pan et al.· Clinical Laboratory· 0 citations
It is suggested that B cells play a major role in the RA immune microenvironment and identify CD83 and CRIP2 as potential biomarkers and therapeutic targets and identify probable diagnostic biomarkers as well as therapeutic targets.
Shi-Kai Chen, Han-Yu Wang, Cheng Wang et al.· Current Medicinal Chemistry· 0 citations
Acute myeloid leukemia (AML) is driven by complex interactions among genetic alterations, metabolic reprogramming, and immune microenvironment dysregulation. Ferroptosis, a form of iron-dependent regulated cell death linking iron metabolism with immune regulation, has been implicated in AML; however, its causal interpl...
Functional enrichment analyses demonstrated that HMOX2 and KPNA2 were identified as Kbhb-related biomarkers in HF, while T cells served as a key cell type in the disease, and novel therapeutic targets for HF patients were provided.
Qing-Kuan Li, Xi-Yong Sheng, Gui-Hua Li et al.· PLoS ONE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.